10-Q
0000105319--12-30falseQ2http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNethttp://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNethttp://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#AssetImpairmentChargeshttp://fasb.org/us-gaap/2022#AssetImpairmentChargeshttp://fasb.org/us-gaap/2022#AssetImpairmentChargeshttp://fasb.org/us-gaap/2022#AssetImpairmentChargeshttp://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrenthttp://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssetsCurrenthttp://fasb.org/us-gaap/2022#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2022#Assetshttp://fasb.org/us-gaap/2022#Assets10000105319ww:InternationalSegmentMemberww:WorkshopsDigitalFeesMember2022-01-022022-07-020000105319ww:CreditFacilitiesAndSeniorSecuredNotesMember2023-07-010000105319us-gaap:LongTermContractWithCustomerMember2022-01-010000105319us-gaap:CommonStockMember2023-07-010000105319ww:InternationalSegmentMember2023-04-022023-07-010000105319us-gaap:ShortTermContractWithCustomerMember2023-01-012023-07-010000105319us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-01-012023-07-010000105319ww:MsWinfreyAndHerRelatedEntitiesMember2023-04-022023-07-010000105319ww:ClinicalSubscriptionRevenuesMember2023-01-012023-07-010000105319us-gaap:TreasuryStockMember2023-07-010000105319ww:DenrossLimitedMember2021-12-212021-12-210000105319us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310000105319ww:WorkshopsDigitalFeesMemberww:NorthAmericaSegmentMember2022-04-032022-07-020000105319us-gaap:CorporateNonSegmentMember2023-04-022023-07-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:LeaseTerminationAndOtherRelatedCostsMember2023-04-022023-07-010000105319us-gaap:TreasuryStockMember2022-04-032022-07-020000105319ww:InternationalMember2022-12-310000105319ww:EightPointSixTwentyFivePercentSeniorNotesDueInTwoThousandTwentyFiveMember2021-04-042021-07-030000105319us-gaap:CorporateNonSegmentMember2022-01-022022-07-020000105319ww:CheckweightLimitedMember2022-02-180000105319ww:EightPointSixTwentyFivePercentSeniorNotesDueInTwoThousandTwentyFiveMember2021-04-132021-04-130000105319srt:MaximumMemberww:SeniorSecuredNotesDueAprilFifteenTwoThousandTwentyNineMembersrt:ScenarioForecastMember2024-04-142024-04-140000105319us-gaap:InterestRateContractMemberus-gaap:InterestExpenseMember2023-01-012023-07-010000105319us-gaap:RetainedEarningsMember2022-07-020000105319ww:CheckweightLimitedMember2023-02-172023-02-170000105319srt:MaximumMember2023-01-012023-07-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:EmployeeTerminationBenefitCostsMember2023-01-012023-07-010000105319us-gaap:RevolvingCreditFacilityMembersrt:MaximumMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-01-012023-07-010000105319ww:SeniorSecuredRevolvingCreditFacilityDueInTwoThousandTwentyTwoMember2021-04-130000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-020000105319us-gaap:LongTermContractWithCustomerMember2022-12-310000105319ww:FiscalYearTwoThousandAndTwentyOnePlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-032022-01-010000105319ww:InterestRateSwapCurrentSwapsMember2023-07-010000105319us-gaap:RetainedEarningsMember2022-12-3100001053192022-12-310000105319us-gaap:InterestRateSwapMember2023-07-010000105319ww:TrademarksAndOtherIntangibleAssetsMember2022-12-3100001053192022-01-010000105319ww:SubscriptionMember2023-01-012023-07-010000105319us-gaap:DebtInstrumentRedemptionPeriodTwoMemberww:SeniorSecuredNotesDueAprilFifteenTwoThousandTwentyNineMember2023-01-012023-07-010000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000105319us-gaap:RevolvingCreditFacilityMembersrt:ScenarioForecastMember2025-03-302025-03-300000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMembersrt:MaximumMembersrt:ScenarioForecastMember2023-01-012023-12-300000105319ww:NorthAmericaSegmentMemberww:SubscriptionRevenuesNetMember2023-04-022023-07-010000105319ww:FiscalYearTwoThousandAndTwentyPlanMemberww:EmployeeTerminationBenefitCostsMember2021-01-032022-01-010000105319ww:WorkshopsDigitalFeesMember2023-01-012023-07-010000105319us-gaap:RetainedEarningsMember2023-01-012023-07-010000105319ww:InternalUseSoftwareContentAndWebsiteDevelopmentMember2023-07-010000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:LeaseTerminationAndOtherRelatedCostsMember2023-01-012023-07-010000105319us-gaap:FranchiseRightsMembercountry:NZ2023-05-070000105319us-gaap:TreasuryStockMember2022-04-020000105319us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2022-12-310000105319ww:DigitalSubscriptionRevenuesMember2022-04-032022-07-020000105319us-gaap:FranchiseRightsMembercountry:NZ2022-04-032022-07-020000105319ww:TwoThousandEighteenSwapMemberus-gaap:InterestRateSwapMember2018-06-110000105319ww:ProductAndOtherMember2023-04-022023-07-010000105319ww:FiscalYearTwoThousandAndTwentyPlanMemberww:LeaseTerminationAndOtherRelatedCostsMember2022-01-022022-12-310000105319ww:FiscalYearTwoThousandAndTwentyOnePlanMemberww:EmployeeTerminationBenefitCostsMember2022-01-022022-12-310000105319us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMember2023-07-0100001053192021-04-042021-07-030000105319ww:FiscalYearTwoThousandAndTwentyOnePlanMemberww:EmployeeTerminationBenefitCostsMember2023-01-012023-07-010000105319ww:ProductSalesAndOtherMember2023-04-022023-07-010000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-022023-07-010000105319us-gaap:ShortTermContractWithCustomerMember2022-01-022022-07-020000105319us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-07-010000105319ww:PurchasePriceAllocationMemberww:WeekendHealthIncDBASequenceMemberus-gaap:CommonStockMember2023-04-100000105319ww:TermLoanFacilityMemberww:SeniorSecuredTrancheBTermLoanMember2021-04-130000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberus-gaap:CostOfSalesMember2023-01-012023-07-010000105319us-gaap:InterestRateContractMemberww:IncomeLossBeforeIncomeTaxesMember2022-04-032022-07-020000105319us-gaap:InterestRateContractMemberus-gaap:InterestExpenseMember2022-04-032022-07-020000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:OtherCostsMembersrt:ScenarioForecastMember2023-01-012023-12-300000105319us-gaap:RevolvingCreditFacilityMemberww:SeniorSecuredRevolvingCreditFacilityMember2021-04-130000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:EmployeeTerminationBenefitCostsMember2023-07-0100001053192023-04-010000105319us-gaap:OperatingSegmentsMember2023-04-022023-07-010000105319us-gaap:CommonStockMember2023-01-012023-07-010000105319us-gaap:OperatingSegmentsMemberww:InternationalMember2023-01-012023-07-010000105319us-gaap:TrademarksMember2022-12-310000105319ww:FiscalYearTwoThousandAndTwentyPlanMemberww:EmployeeTerminationBenefitCostsMember2019-12-292021-01-020000105319us-gaap:FranchiseRightsMembercountry:US2023-07-010000105319us-gaap:OperatingSegmentsMemberww:NorthAmericaSegmentMember2022-01-022022-07-020000105319us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2022-12-310000105319ww:DigitalSubscriptionRevenuesMemberww:InternationalSegmentMember2023-01-012023-07-010000105319ww:InternationalMember2023-01-012023-07-010000105319us-gaap:InterestRateContractMemberus-gaap:OperatingIncomeLossMember2022-01-022022-07-020000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:LeaseImpairmentMember2022-01-022022-12-310000105319us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2022-01-010000105319ww:SubscriptionMember2023-04-022023-07-010000105319us-gaap:InterestRateContractMemberww:ProvisionForBenefitFromIncomeTaxesMember2023-04-022023-07-010000105319ww:InternationalMember2022-01-022022-12-310000105319ww:FiscalYearTwoThousandAndTwentyPlanMemberus-gaap:CostOfSalesMember2019-12-292021-01-020000105319ww:WeekendHealthIncDBASequenceMember2023-04-022023-07-010000105319ww:ClinicalSubscriptionRevenuesMember2023-04-022023-07-010000105319ww:SeniorSecuredTrancheBTermLoanMember2021-04-132021-04-130000105319us-gaap:RevolvingCreditFacilityMemberww:SeniorSecuredRevolvingCreditFacilityMember2021-04-132021-04-130000105319ww:WeekendHealthIncDBASequenceMember2023-04-102023-04-100000105319ww:TwoThousandNineteenSwapMemberus-gaap:InterestRateSwapMember2019-06-072019-06-070000105319ww:TwoThousandEighteenSwapMemberus-gaap:InterestRateSwapMember2018-06-112018-06-110000105319us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-07-010000105319us-gaap:TreasuryStockMember2022-01-022022-07-020000105319ww:KurboIncMember2022-04-032022-07-020000105319us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberww:TermLoanFacilityDueAprilThirteenTwoThousandTwentyEightMember2023-07-010000105319ww:SeniorSecuredNotesDueAprilFifteenTwoThousandTwentyNineMemberus-gaap:DebtInstrumentRedemptionPeriodThreeMember2023-01-012023-07-010000105319ww:DenrossLimitedMember2022-02-182022-02-180000105319us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310000105319ww:FiscalYearTwoThousandAndTwentyPlanMemberww:LeaseTerminationAndOtherRelatedCostsMember2021-01-032022-01-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:EmployeeTerminationBenefitCostsMember2022-01-022022-12-310000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:EmployeeTerminationBenefitCostsMember2023-01-012023-07-010000105319srt:MaximumMember2023-05-072023-05-070000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMembersrt:MaximumMembersrt:ScenarioForecastMember2023-01-012023-12-300000105319ww:DenrossLimitedMember2023-02-172023-02-170000105319country:IE2023-05-0700001053192022-04-020000105319ww:SubscriptionRevenuesNetMemberww:NorthAmericaSegmentMember2022-04-032022-07-020000105319us-gaap:InterestRateContractMemberww:IncomeLossBeforeIncomeTaxesMember2023-04-022023-07-010000105319ww:ProductSalesAndOtherMemberww:NorthAmericaSegmentMember2023-04-022023-07-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:OrganizationalRestructuringMemberww:EmployeeTerminationBenefitCostsMember2023-01-012023-07-010000105319ww:FourPointFiveZeroZeroPercentSeniorSecuredNotesDue2029Member2021-04-130000105319ww:IncomeTaxExpenseBenefitMember2022-04-032022-07-020000105319ww:TwelveMonthTermSecuredOvernightFinancingRateSofrMember2023-07-012023-07-010000105319ww:TerminationOfRule10B51PlanMemberww:FoundationMember2023-01-012023-07-010000105319us-gaap:ComputerSoftwareIntangibleAssetMember2023-07-010000105319ww:InternationalMember2022-01-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:OrganizationalRestructuringMemberww:EmployeeTerminationBenefitCostsMember2022-01-022022-12-310000105319ww:NorthAmericaSegmentMember2022-04-032022-07-020000105319us-gaap:CashFlowHedgingMemberww:TwoThousandEighteenSwapMemberus-gaap:InterestRateSwapMember2020-04-020000105319ww:OtherCountriesMember2023-07-010000105319us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-01-012023-07-010000105319us-gaap:LongTermContractWithCustomerMember2022-07-020000105319ww:KurboHealthIncMember2018-08-102018-08-100000105319us-gaap:InterestRateContractMemberww:ProvisionForBenefitFromIncomeTaxesMember2022-04-032022-07-020000105319us-gaap:FranchiseRightsMembersrt:MinimumMember2023-05-072023-05-070000105319us-gaap:RevolvingCreditFacilityMemberww:FederalFundsEffectiveRateMember2023-01-012023-07-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:OrganizationalRestructuringMemberww:EmployeeTerminationBenefitCostsMember2023-04-022023-07-010000105319ww:CreditFacilitiesMember2021-04-132021-04-130000105319ww:ThreeMonthTermSecuredOvernightFinancingRateSofrMember2023-07-012023-07-010000105319ww:FiscalYearTwoThousandAndTwentyOnePlanMemberww:LeaseTerminationAndOtherRelatedCostsMember2023-07-010000105319us-gaap:OtherIntangibleAssetsMember2022-12-310000105319us-gaap:RetainedEarningsMember2022-01-022022-07-020000105319us-gaap:OperatingSegmentsMember2022-01-022022-07-020000105319us-gaap:CommonStockMember2022-12-310000105319us-gaap:LongTermContractWithCustomerMember2023-07-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:OrganizationalRestructuringMemberww:EmployeeTerminationBenefitCostsMember2023-07-010000105319ww:InternalUseSoftwareContentAndWebsiteDevelopmentMember2022-12-310000105319ww:FiscalYearTwoThousandAndTwentyOnePlanMemberww:LeaseTerminationAndOtherRelatedCostsMember2021-01-032022-01-010000105319ww:AdoptionOfRule10B51PlanMemberww:FoundationMember2023-01-012023-07-010000105319ww:NorthAmericaSegmentMemberww:SubscriptionRevenuesNetMember2023-01-012023-07-010000105319srt:MaximumMember2022-05-082022-05-080000105319ww:WorkshopsDigitalFeesMember2023-04-022023-07-010000105319ww:FiscalYearTwoThousandAndTwentyPlanMember2019-12-292021-01-020000105319us-gaap:RetainedEarningsMember2023-04-010000105319us-gaap:FranchiseRightsMembercountry:CA2022-04-032022-07-020000105319ww:WorkshopsDigitalFeesMemberww:NorthAmericaSegmentMember2023-04-022023-07-010000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-022022-07-020000105319ww:DigitalSubscriptionRevenuesMemberww:InternationalSegmentMember2022-01-022022-07-020000105319ww:TerminationOfRule10B51PlanMemberus-gaap:EmployeeStockOptionMember2023-01-012023-07-010000105319ww:InternationalSegmentMemberww:ProductSalesAndOtherMember2023-04-022023-07-010000105319us-gaap:FranchiseRightsMembersrt:MaximumMember2023-01-012023-07-010000105319ww:InternationalSegmentMemberww:WorkshopsDigitalFeesMember2023-01-012023-07-010000105319us-gaap:RetainedEarningsMember2022-01-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMembersrt:MinimumMembersrt:ScenarioForecastMember2023-01-012023-12-300000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberus-gaap:OtherRestructuringMember2023-01-012023-07-010000105319ww:SubscriptionMember2022-01-022022-07-020000105319ww:TrademarksAndOtherIntangibleAssetsMember2023-07-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:LeaseTerminationAndOtherRelatedCostsMember2023-01-012023-07-010000105319ww:AllReportingUnitsExceptForRepublicOfIrelandMembersrt:MinimumMemberus-gaap:GoodwillMember2023-05-070000105319ww:WeekendHealthIncDBASequenceMember2023-01-012023-07-010000105319ww:DigitalSubscriptionRevenuesMember2023-01-012023-07-010000105319ww:FiscalYearTwoThousandAndTwentyOnePlanMemberus-gaap:CostOfSalesMember2021-01-032022-01-010000105319us-gaap:TreasuryStockMember2022-07-020000105319ww:WorkshopsDigitalFeesMemberww:NorthAmericaSegmentMember2022-01-022022-07-020000105319us-gaap:RevolvingCreditFacilityMembersrt:ScenarioForecastMember2024-03-312025-03-290000105319ww:DigitalSubscriptionRevenuesMemberww:InternationalSegmentMember2023-04-022023-07-010000105319us-gaap:DebtInstrumentRedemptionPeriodOneMemberww:SeniorSecuredNotesDueAprilFifteenTwoThousandTwentyNineMember2023-01-012023-07-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-04-022023-07-010000105319us-gaap:RevolvingCreditFacilityMembersrt:ScenarioForecastMember2023-04-022024-03-300000105319us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2022-12-310000105319ww:MsWinfreyAndHerRelatedEntitiesMember2022-12-310000105319ww:NorthAmericaSegmentMember2022-01-022022-12-3100001053192023-04-022023-07-010000105319ww:DigitalSubscriptionRevenuesMember2023-04-022023-07-010000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:LeaseTerminationAndOtherRelatedCostsMember2022-01-022022-12-310000105319ww:FiscalYearTwoThousandAndTwentyPlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2019-12-292021-01-020000105319ww:DigitalSubscriptionRevenuesMemberww:NorthAmericaSegmentMember2022-01-022022-07-020000105319us-gaap:RetainedEarningsMember2022-04-020000105319ww:InternationalMember2022-01-022022-07-020000105319ww:InternationalSegmentMemberww:SubscriptionRevenuesNetMember2023-01-012023-07-010000105319ww:InternationalMember2022-04-032022-07-020000105319ww:TermLoanFacilityMemberww:SeniorSecuredTrancheBTermLoanMember2021-10-032022-01-010000105319ww:AllReportingUnitsExceptForRepublicOfIrelandMember2023-07-010000105319us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2023-07-010000105319ww:ProductSalesAndOtherMemberww:NorthAmericaSegmentMember2022-01-022022-07-020000105319ww:DigitalSubscriptionRevenuesMember2022-01-022022-07-020000105319us-gaap:CustomerRelationshipsMemberww:DenrossLimitedMember2022-02-1800001053192022-07-020000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberus-gaap:OtherRestructuringMember2023-04-022023-07-010000105319ww:TermLoanFacilityDueAprilThirteenTwoThousandTwentyEightMember2023-07-010000105319ww:WorkshopsDigitalFeesMember2022-04-032022-07-020000105319us-gaap:ShortTermContractWithCustomerMember2022-12-310000105319ww:MsWinfreyAndHerRelatedEntitiesMember2023-07-010000105319us-gaap:FranchiseRightsMembercountry:AU2023-07-010000105319ww:NorthAmericaSegmentMember2023-04-022023-07-010000105319ww:WeekendHealthIncDBASequenceMemberus-gaap:CommonStockMember2023-04-100000105319us-gaap:OperatingSegmentsMemberww:NorthAmericaSegmentMember2022-04-032022-07-020000105319ww:ProductSalesAndOtherMember2022-04-032022-07-020000105319ww:DenrossLimitedMember2022-02-1800001053192022-01-022022-12-310000105319ww:WeekendHealthIncDBASequenceMember2023-04-100000105319us-gaap:OperatingSegmentsMemberww:InternationalMember2022-04-032022-07-020000105319ww:FiscalYearTwoThousandAndTwentyPlanMemberww:LeaseTerminationAndOtherRelatedCostsMember2023-07-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberus-gaap:CostOfSalesMember2023-04-022023-07-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberus-gaap:CostOfSalesMember2022-01-022022-12-310000105319ww:FiscalYearTwoThousandAndTwentyOnePlanMember2021-01-032022-01-010000105319ww:FiscalYearTwoThousandAndTwentyOnePlanMemberww:EmployeeTerminationBenefitCostsMember2023-07-010000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberus-gaap:CostOfSalesMember2022-01-022022-12-310000105319srt:MinimumMember2023-05-072023-05-070000105319ww:AdoptionOfRule10B51PlanMemberww:OprahWinfreyDirectorMember2023-01-012023-07-010000105319ww:FiscalYearTwoThousandAndTwentyOnePlanMemberww:LeaseTerminationAndOtherRelatedCostsMember2022-01-022022-12-310000105319us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberww:TermLoanFacilityDueAprilThirteenTwoThousandTwentyEightMember2023-01-012023-07-010000105319ww:ProductAndOtherMember2022-01-022022-07-020000105319ww:SubscriptionMember2022-04-032022-07-020000105319us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-01-022022-07-020000105319ww:MsWinfreyAndHerRelatedEntitiesMember2023-01-012023-07-010000105319ww:AdoptionOfRule10B51PlanMember2023-01-012023-07-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMember2022-01-022022-12-3100001053192022-04-032022-07-020000105319ww:FiscalYearTwoThousandAndTwentyPlanMemberww:LeaseTerminationAndOtherRelatedCostsMember2019-12-292021-01-020000105319ww:WorkshopsDigitalFeesMemberww:NorthAmericaSegmentMember2023-01-012023-07-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMembersrt:MinimumMembersrt:ScenarioForecastMember2023-01-012023-12-3000001053192022-05-082022-05-080000105319ww:TermLoanFacilityDueAprilThirteenTwoThousandTwentyEightMember2021-07-030000105319ww:NorthAmericaSegmentMember2023-01-012023-07-010000105319us-gaap:OperatingSegmentsMember2023-01-012023-07-010000105319ww:InternationalSegmentMember2023-01-012023-07-010000105319ww:CheckweightLimitedMember2022-02-182022-02-180000105319ww:FiscalYearTwoThousandAndTwentyPlanMemberww:EmployeeTerminationBenefitCostsMember2023-07-010000105319us-gaap:TreasuryStockMember2023-01-012023-07-010000105319us-gaap:FranchiseRightsMembercountry:NZ2023-07-010000105319us-gaap:InterestRateContractMemberww:ProvisionForBenefitFromIncomeTaxesMember2023-01-012023-07-010000105319ww:InternationalSegmentMemberww:WorkshopsDigitalFeesMember2022-04-032022-07-020000105319us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-07-010000105319us-gaap:CashFlowHedgingMemberww:TwoThousandEighteenSwapMemberus-gaap:InterestRateSwapMember2018-06-110000105319us-gaap:CorporateNonSegmentMember2023-01-012023-07-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:OrganizationalRestructuringMembersrt:MinimumMemberus-gaap:GeneralAndAdministrativeExpenseMembersrt:ScenarioForecastMember2023-01-012023-12-300000105319ww:AdoptionOfRule10B51PlanMemberus-gaap:EmployeeStockOptionMember2023-01-012023-07-010000105319us-gaap:TreasuryStockMember2022-12-310000105319country:CA2023-07-010000105319ww:SubscriptionRevenuesNetMember2022-04-032022-07-020000105319ww:SeniorSecuredNotesDueAprilFifteenTwoThousandTwentyNineMembersrt:ScenarioForecastMember2023-04-162024-04-150000105319ww:MsWinfreyAndHerRelatedEntitiesMember2022-04-032022-07-020000105319ww:ProductSalesAndOtherMember2023-01-012023-07-010000105319ww:FiscalYearTwoThousandAndTwentyPlanMemberww:EmployeeTerminationBenefitCostsMember2022-01-022022-12-310000105319us-gaap:LongTermContractWithCustomerMember2022-01-022022-07-020000105319us-gaap:CashFlowHedgingMemberww:TwoThousandEighteenSwapMemberus-gaap:InterestRateSwapMember2021-03-312021-03-310000105319srt:MaximumMemberww:SeniorSecuredNotesDueAprilFifteenTwoThousandTwentyNineMembersrt:ScenarioForecastMember2023-04-162024-04-150000105319ww:SeniorSecuredNotesDueAprilFifteenTwoThousandTwentyNineMember2023-01-012023-07-010000105319us-gaap:RetainedEarningsMember2023-04-022023-07-010000105319ww:SixMonthTermSecuredOvernightFinancingRateSofrMember2023-07-012023-07-010000105319ww:FiscalYearTwoThousandAndTwentyPlanMemberww:EmployeeTerminationBenefitCostsMember2023-01-012023-07-010000105319us-gaap:ComputerSoftwareIntangibleAssetMember2022-12-310000105319ww:SeniorSecuredNotesDueAprilFifteenTwoThousandTwentyNineMemberww:ChangeOfControlMember2023-01-012023-07-010000105319us-gaap:RevolvingCreditFacilityMemberww:SeniorSecuredRevolvingCreditFacilityDueInTwoThousandTwentyTwoMember2021-04-132021-04-130000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:EmployeeTerminationBenefitCostsMember2023-07-010000105319ww:ProductSalesAndOtherMemberww:NorthAmericaSegmentMember2022-04-032022-07-020000105319us-gaap:OperatingSegmentsMemberww:NorthAmericaSegmentMember2023-04-022023-07-010000105319us-gaap:RetainedEarningsMember2022-04-032022-07-020000105319ww:TermLoanFacilityMemberww:SeniorSecuredTrancheBTermLoanMember2021-12-012021-12-310000105319us-gaap:FranchiseRightsMember2022-12-3100001053192023-01-012023-04-010000105319us-gaap:InterestRateContractMemberww:ProvisionForBenefitFromIncomeTaxesMember2022-01-022022-07-020000105319ww:InternationalSegmentMemberww:WorkshopsDigitalFeesMember2023-04-022023-07-010000105319ww:NorthAmericaSegmentMember2022-12-310000105319us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2022-07-020000105319ww:InternationalSegmentMember2022-01-022022-07-020000105319us-gaap:TreasuryStockMember2023-04-0100001053192023-07-010000105319us-gaap:OperatingSegmentsMemberww:NorthAmericaSegmentMember2023-01-012023-07-010000105319us-gaap:FranchiseRightsMembersrt:MaximumMember2023-05-072023-05-070000105319us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-12-3100001053192023-07-270000105319ww:TerminationOfRule10B51PlanMember2023-01-012023-07-010000105319ww:PurchasePriceAllocationMemberww:WeekendHealthIncDBASequenceMemberus-gaap:CommonStockMember2023-04-102023-04-100000105319us-gaap:OperatingSegmentsMember2022-04-032022-07-020000105319ww:SubscriptionRevenuesNetMember2022-01-022022-07-020000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-022022-12-310000105319us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-01-010000105319us-gaap:FranchiseRightsMembercountry:GB2023-07-010000105319us-gaap:TreasuryStockMember2022-01-010000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-010000105319us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-07-010000105319us-gaap:InterestRateContractMemberww:IncomeLossBeforeIncomeTaxesMember2022-01-022022-07-020000105319ww:TermLoanFacilityDueAprilThirteenTwoThousandTwentyEightMember2022-12-310000105319us-gaap:LongTermContractWithCustomerMember2023-01-012023-07-0100001053192023-01-012023-07-010000105319us-gaap:RetainedEarningsMember2023-07-010000105319ww:FiscalYearTwoThousandAndTwentyOnePlanMemberww:EmployeeTerminationBenefitCostsMember2021-01-032022-01-010000105319ww:TwoThousandNineteenSwapMemberus-gaap:InterestRateSwapMember2019-06-0700001053192022-01-022022-07-020000105319us-gaap:InterestRateContractMemberus-gaap:OperatingIncomeLossMember2023-04-022023-07-0100001053192015-10-182015-10-180000105319us-gaap:InterestRateContractMemberus-gaap:InterestExpenseMember2023-04-022023-07-010000105319ww:InternationalSegmentMemberww:ProductSalesAndOtherMember2023-01-012023-07-010000105319ww:NorthAmericaSegmentMember2022-01-010000105319us-gaap:CashFlowHedgingMemberww:TwoThousandEighteenSwapMemberus-gaap:InterestRateSwapMember2020-04-022020-04-020000105319us-gaap:FranchiseRightsMembersrt:MinimumMemberww:AllUnitsOfAccountExceptForNewZealandMember2023-05-070000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:EmployeeTerminationBenefitCostsMember2023-04-022023-07-010000105319us-gaap:InterestRateContractMemberus-gaap:OperatingIncomeLossMember2022-04-032022-07-020000105319us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2022-01-010000105319ww:CreditFacilitiesMember2023-07-010000105319us-gaap:FranchiseRightsMember2023-05-072023-05-070000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-07-010000105319us-gaap:ShortTermContractWithCustomerMember2022-07-020000105319ww:InternationalMember2023-04-022023-07-010000105319ww:InternationalSegmentMemberww:ProductSalesAndOtherMember2022-04-032022-07-020000105319ww:NorthAmericaSegmentMember2022-01-022022-07-020000105319us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-07-020000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:LeaseTerminationAndOtherRelatedCostsMember2023-07-010000105319us-gaap:FranchiseRightsMemberww:CheckweightLimitedMember2022-02-180000105319ww:ClinicalSubscriptionRevenuesMemberww:NorthAmericaSegmentMember2023-01-012023-07-010000105319ww:WorkshopsDigitalFeesMember2022-01-022022-07-020000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMember2023-04-022023-07-010000105319us-gaap:CommonStockMember2022-01-010000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-010000105319ww:ProductAndOtherMember2022-04-032022-07-020000105319ww:InternationalSegmentMemberww:SubscriptionRevenuesNetMember2023-04-022023-07-010000105319ww:InternationalMember2023-07-010000105319us-gaap:ShortTermContractWithCustomerMember2022-01-010000105319us-gaap:InterestRateSwapMember2022-12-310000105319ww:InternationalSegmentMember2022-04-032022-07-020000105319us-gaap:RevolvingCreditFacilityMember2023-07-010000105319us-gaap:CommonStockMember2023-04-022023-07-010000105319ww:DigitalSubscriptionRevenuesMemberww:NorthAmericaSegmentMember2023-01-012023-07-010000105319us-gaap:CommonStockMember2022-04-020000105319ww:DigitalSubscriptionRevenuesMemberww:InternationalSegmentMember2022-04-032022-07-020000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMember2023-01-012023-07-010000105319us-gaap:CashFlowHedgingMemberww:TwoThousandNineteenSwapMemberus-gaap:InterestRateSwapMember2019-06-070000105319country:IE2023-07-010000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberus-gaap:OtherRestructuringMember2022-01-022022-12-310000105319us-gaap:InterestRateContractMemberus-gaap:InterestExpenseMember2022-01-022022-07-020000105319ww:EightPointSixTwentyFivePercentSeniorNotesDueInTwoThousandTwentyFiveMember2021-04-130000105319ww:PurchasePriceAllocationMemberww:WeekendHealthIncDBASequenceMember2023-04-102023-04-100000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-010000105319us-gaap:CustomerRelationshipsMemberww:CheckweightLimitedMember2022-02-180000105319ww:PurchasePriceAllocationMemberww:WeekendHealthIncDBASequenceMember2023-04-100000105319us-gaap:RevolvingCreditFacilityMemberww:SeniorSecuredRevolvingCreditFacilityDueInTwoThousandTwentyTwoMember2021-04-130000105319us-gaap:InterestRateContractMemberus-gaap:OperatingIncomeLossMember2023-01-012023-07-010000105319ww:SeniorSecuredNotesDueAprilFifteenTwoThousandTwentyNineMember2023-07-010000105319ww:SeniorSecuredNotesDueAprilFifteenTwoThousandTwentyNineMember2022-12-310000105319ww:OneMonthTermSecuredOvernightFinancingRateSofrMember2023-07-012023-07-010000105319us-gaap:OtherIntangibleAssetsMember2023-07-010000105319us-gaap:InterestRateContractMemberww:IncomeLossBeforeIncomeTaxesMember2023-01-012023-07-010000105319us-gaap:TreasuryStockMember2023-04-022023-07-010000105319ww:ProductSalesAndOtherMemberww:NorthAmericaSegmentMember2023-01-012023-07-010000105319ww:InternationalSegmentMemberww:SubscriptionRevenuesNetMember2022-04-032022-07-020000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-020000105319ww:ProductSalesAndOtherMember2022-01-022022-07-020000105319ww:SubscriptionRevenuesNetMember2023-04-022023-07-010000105319ww:InternationalSegmentMemberww:SubscriptionRevenuesNetMember2022-01-022022-07-020000105319ww:InterestRateSwapCurrentSwapsMember2022-12-310000105319us-gaap:FranchiseRightsMemberww:OtherUnitsOfAccountMember2022-05-082022-05-080000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-032022-07-020000105319ww:NorthAmericaSegmentMemberww:SubscriptionRevenuesNetMember2022-01-022022-07-020000105319ww:TermLoanFacilityMemberww:SeniorSecuredTrancheBTermLoanMember2021-04-132021-04-130000105319ww:InternationalSegmentMemberww:ProductSalesAndOtherMember2022-01-022022-07-020000105319us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-07-010000105319us-gaap:CommonStockMember2023-04-0100001053192023-05-072023-05-070000105319srt:MinimumMember2022-05-082022-05-080000105319ww:DigitalSubscriptionRevenuesMemberww:NorthAmericaSegmentMember2022-04-032022-07-020000105319us-gaap:FranchiseRightsMemberww:AllUnitsOfAccountExceptForNewZealandMember2023-07-010000105319us-gaap:RevolvingCreditFacilityMember2022-12-310000105319ww:IncomeTaxExpenseBenefitMember2022-01-022022-07-020000105319ww:MsWinfreyAndHerRelatedEntitiesMember2022-01-022022-07-020000105319ww:TerminationOfRule10B51PlanMemberww:OprahWinfreyDirectorMember2023-01-012023-07-010000105319us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2022-07-020000105319ww:WeekendHealthIncDBASequenceMemberus-gaap:CommonStockMember2023-04-102023-04-100000105319ww:FederalFundsEffectiveRateMemberww:TermLoanFacilityDueAprilThirteenTwoThousandTwentyEightMember2023-01-012023-07-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:OrganizationalRestructuringMembersrt:MaximumMemberus-gaap:GeneralAndAdministrativeExpenseMembersrt:ScenarioForecastMember2023-01-012023-12-300000105319us-gaap:TrademarksMember2023-07-010000105319ww:SaleOfAssetsMemberww:SeniorSecuredNotesDueAprilFifteenTwoThousandTwentyNineMember2023-01-012023-07-010000105319us-gaap:OperatingSegmentsMemberww:InternationalMember2022-01-022022-07-020000105319us-gaap:OperatingSegmentsMemberww:InternationalMember2023-04-022023-07-010000105319us-gaap:CommonStockMember2022-07-020000105319ww:ProductAndOtherMember2023-01-012023-07-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:LeaseTerminationAndOtherRelatedCostsMember2023-07-010000105319country:US2023-07-010000105319us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-01-012023-07-010000105319us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2022-01-022022-07-020000105319srt:MaximumMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberww:TermLoanFacilityDueAprilThirteenTwoThousandTwentyEightMember2023-01-012023-07-010000105319ww:KurboHealthIncMember2018-08-100000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-022022-12-310000105319us-gaap:ShortTermContractWithCustomerMember2023-07-010000105319srt:MinimumMember2023-01-012023-07-010000105319us-gaap:CashFlowHedgingMemberww:TwoThousandEighteenSwapMemberus-gaap:InterestRateSwapMember2021-03-310000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:EmployeeTerminationBenefitCostsMember2022-01-022022-12-310000105319us-gaap:CorporateNonSegmentMember2022-04-032022-07-020000105319ww:SubscriptionRevenuesNetMember2023-01-012023-07-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-07-010000105319ww:NorthAmericaSegmentMember2023-07-010000105319ww:ClinicalSubscriptionRevenuesMemberww:NorthAmericaSegmentMember2023-04-022023-07-010000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMember2022-01-022022-12-310000105319us-gaap:RevolvingCreditFacilityMember2023-01-012023-07-010000105319us-gaap:FranchiseRightsMember2023-07-010000105319ww:DigitalSubscriptionRevenuesMemberww:NorthAmericaSegmentMember2023-04-022023-07-01xbrli:purexbrli:sharesww:Segmentiso4217:USD
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
|
|
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended July 1, 2023
OR
|
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 001-16769
WW INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
|
|
|
Virginia |
|
11-6040273 |
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
675 Avenue of the Americas, 6th Floor, New York, New York 10010
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (212) 589-2700
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Common Stock, no par value |
WW |
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
Large accelerated filer |
|
☐ |
Accelerated filer |
|
☒ |
|
|
|
|
|
|
Non-accelerated filer |
|
☐ |
Smaller reporting company |
|
☐ |
|
|
|
|
|
|
|
|
|
Emerging growth company |
|
☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The number of shares of common stock outstanding as of July 27, 2023 was 78,966,060.
WW INTERNATIONAL, INC.
TABLE OF CONTENTS
|
|
|
|
|
Page No. |
|
|
|
PART I—FINANCIAL INFORMATION |
|
|
|
|
Item 1. |
Financial Statements |
2 |
|
|
|
|
Unaudited Consolidated Balance Sheets at July 1, 2023 and December 31, 2022 |
2 |
|
|
|
|
Unaudited Consolidated Statements of Operations for the three and six months ended July 1, 2023 and July 2, 2022 |
3 |
|
|
|
|
Unaudited Consolidated Statements of Comprehensive Income (Loss) for the three and six months ended July 1, 2023 and July 2, 2022 |
4 |
|
|
|
|
Unaudited Consolidated Statements of Changes in Total Deficit for the three and six months ended July 1, 2023 and July 2, 2022 |
5 |
|
|
|
|
Unaudited Consolidated Statements of Cash Flows for the six months ended July 1, 2023 and July 2, 2022 |
6 |
|
|
|
|
Notes to Unaudited Consolidated Financial Statements |
7 |
|
|
|
Cautionary Notice Regarding Forward-Looking Statements |
29 |
|
|
|
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
31 |
|
|
|
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk |
55 |
|
|
|
Item 4. |
Controls and Procedures |
55 |
|
|
|
PART II—OTHER INFORMATION |
|
|
|
|
Item 1. |
Legal Proceedings |
57 |
|
|
|
Item 1A. |
Risk Factors |
57 |
|
|
|
Item 2. |
Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities |
62 |
|
|
|
Item 3. |
Defaults Upon Senior Securities |
62 |
|
|
|
Item 4. |
Mine Safety Disclosures |
62 |
|
|
|
Item 5. |
Other Information |
62 |
|
|
|
Item 6. |
Exhibits |
64 |
|
|
|
Signatures |
65 |
PART I—FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
WW INTERNATIONAL, INC. AND SUBSIDIARIES
UNAUDITED CONSOLIDATED BALANCE SHEETS AT
(IN THOUSANDS)
|
|
|
|
|
|
|
|
|
|
|
July 1, |
|
|
December 31, |
|
|
|
2023 |
|
|
2022 |
|
ASSETS |
|
|
|
|
|
|
CURRENT ASSETS |
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
91,446 |
|
|
$ |
178,326 |
|
Receivables (net of allowances: July 1, 2023 - $907 and December 31, 2022 - $976) |
|
|
25,813 |
|
|
|
24,273 |
|
Inventories |
|
|
10,834 |
|
|
|
20,528 |
|
Derivative receivable |
|
|
10,546 |
|
|
|
11,748 |
|
Prepaid income taxes |
|
|
17,173 |
|
|
|
19,447 |
|
Prepaid expenses and other current assets |
|
|
22,110 |
|
|
|
27,009 |
|
TOTAL CURRENT ASSETS |
|
|
177,922 |
|
|
|
281,331 |
|
Property and equipment, net |
|
|
23,569 |
|
|
|
28,229 |
|
Operating lease assets |
|
|
58,019 |
|
|
|
75,696 |
|
Franchise rights acquired |
|
|
386,555 |
|
|
|
386,745 |
|
Goodwill |
|
|
246,208 |
|
|
|
155,998 |
|
Other intangible assets, net |
|
|
71,091 |
|
|
|
63,306 |
|
Deferred income taxes |
|
|
22,403 |
|
|
|
22,246 |
|
Other noncurrent assets |
|
|
15,716 |
|
|
|
14,879 |
|
TOTAL ASSETS |
|
$ |
1,001,483 |
|
|
$ |
1,028,430 |
|
LIABILITIES AND TOTAL DEFICIT |
|
|
|
|
|
|
CURRENT LIABILITIES |
|
|
|
|
|
|
Portion of operating lease liabilities due within one year |
|
$ |
9,949 |
|
|
$ |
17,955 |
|
Accounts payable |
|
|
21,998 |
|
|
|
18,890 |
|
Salaries and wages payable |
|
|
55,198 |
|
|
|
72,577 |
|
Accrued marketing and advertising |
|
|
12,290 |
|
|
|
17,927 |
|
Accrued interest |
|
|
5,333 |
|
|
|
5,289 |
|
Other accrued liabilities |
|
|
53,739 |
|
|
|
30,118 |
|
Income taxes payable |
|
|
7,198 |
|
|
|
1,646 |
|
Deferred revenue |
|
|
35,705 |
|
|
|
32,156 |
|
TOTAL CURRENT LIABILITIES |
|
|
201,410 |
|
|
|
196,558 |
|
Long-term debt, net |
|
|
1,424,374 |
|
|
|
1,422,284 |
|
Long-term operating lease liabilities |
|
|
58,867 |
|
|
|
68,099 |
|
Deferred income taxes |
|
|
18,184 |
|
|
|
23,119 |
|
Other |
|
|
14,910 |
|
|
|
2,185 |
|
TOTAL LIABILITIES |
|
|
1,717,745 |
|
|
|
1,712,245 |
|
TOTAL DEFICIT |
|
|
|
|
|
|
Common stock, $0 par value; 1,000,000 shares authorized; 130,048 shares issued at July 1, 2023 and 122,052 shares issued at December 31, 2022 |
|
|
0 |
|
|
|
0 |
|
Treasury stock, at cost, 51,146 shares at July 1, 2023 and 51,496 shares at December 31, 2022 |
|
|
(3,079,073 |
) |
|
|
(3,097,304 |
) |
Retained earnings |
|
|
2,370,340 |
|
|
|
2,418,959 |
|
Accumulated other comprehensive loss |
|
|
(7,529 |
) |
|
|
(5,470 |
) |
TOTAL DEFICIT |
|
|
(716,262 |
) |
|
|
(683,815 |
) |
TOTAL LIABILITIES AND TOTAL DEFICIT |
|
$ |
1,001,483 |
|
|
$ |
1,028,430 |
|
The accompanying notes are an integral part of the consolidated financial statements.
2
WW INTERNATIONAL, INC. AND SUBSIDIARIES
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
July 1, |
|
|
July 2, |
|
|
July 1, |
|
|
July 2, |
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Subscription revenues, net |
$ |
212,140 |
|
|
$ |
240,391 |
|
|
$ |
423,172 |
|
|
$ |
497,376 |
|
Product sales and other, net |
|
14,690 |
|
|
|
29,063 |
|
|
|
45,552 |
|
|
|
69,838 |
|
Revenues, net |
|
226,830 |
|
|
|
269,454 |
|
|
|
468,724 |
|
|
|
567,214 |
|
Cost of subscription revenues |
|
71,378 |
|
|
|
84,129 |
|
|
|
166,275 |
|
|
|
170,170 |
|
Cost of product sales and other |
|
12,272 |
|
|
|
22,363 |
|
|
|
39,758 |
|
|
|
53,985 |
|
Cost of revenues |
|
83,650 |
|
|
|
106,492 |
|
|
|
206,033 |
|
|
|
224,155 |
|
Gross profit |
|
143,180 |
|
|
|
162,962 |
|
|
|
262,691 |
|
|
|
343,059 |
|
Marketing expenses |
|
51,119 |
|
|
|
51,857 |
|
|
|
139,353 |
|
|
|
159,427 |
|
Selling, general and administrative expenses |
|
65,744 |
|
|
|
71,319 |
|
|
|
125,604 |
|
|
|
134,877 |
|
Franchise rights acquired and goodwill impairments |
|
— |
|
|
|
26,420 |
|
|
|
— |
|
|
|
26,420 |
|
Operating income (loss) |
|
26,317 |
|
|
|
13,366 |
|
|
|
(2,266 |
) |
|
|
22,335 |
|
Interest expense |
|
24,075 |
|
|
|
19,255 |
|
|
|
46,921 |
|
|
|
37,926 |
|
Other (income) expense, net |
|
(520 |
) |
|
|
1,613 |
|
|
|
(851 |
) |
|
|
1,956 |
|
Income (loss) before income taxes |
|
2,762 |
|
|
|
(7,502 |
) |
|
|
(48,336 |
) |
|
|
(17,547 |
) |
(Benefit from) provision for income taxes |
|
(48,066 |
) |
|
|
(2,879 |
) |
|
|
19,515 |
|
|
|
(4,681 |
) |
Net income (loss) |
$ |
50,828 |
|
|
$ |
(4,623 |
) |
|
$ |
(67,851 |
) |
|
$ |
(12,866 |
) |
Earnings (net loss) per share |
|
|
|
|
|
|
|
|
|
|
|
Basic |
$ |
0.65 |
|
|
$ |
(0.07 |
) |
|
$ |
(0.91 |
) |
|
$ |
(0.18 |
) |
Diluted |
$ |
0.65 |
|
|
$ |
(0.07 |
) |
|
$ |
(0.91 |
) |
|
$ |
(0.18 |
) |
Weighted average common shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
78,007 |
|
|
|
70,305 |
|
|
|
74,302 |
|
|
|
70,195 |
|
Diluted |
|
78,591 |
|
|
|
70,305 |
|
|
|
74,302 |
|
|
|
70,195 |
|
The accompanying notes are an integral part of the consolidated financial statements.
3
WW INTERNATIONAL, INC. AND SUBSIDIARIES
UNAUDITED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(IN THOUSANDS)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
July 1, |
|
|
July 2, |
|
|
July 1, |
|
|
July 2, |
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Net income (loss) |
$ |
50,828 |
|
|
$ |
(4,623 |
) |
|
$ |
(67,851 |
) |
|
$ |
(12,866 |
) |
Other comprehensive gain (loss): |
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation gain (loss) |
|
816 |
|
|
|
(8,325 |
) |
|
|
929 |
|
|
|
(8,466 |
) |
Income tax (expense) benefit on foreign currency translation gain (loss) |
|
(204 |
) |
|
|
2,089 |
|
|
|
(232 |
) |
|
|
2,125 |
|
Foreign currency translation gain (loss), net of taxes |
|
612 |
|
|
|
(6,236 |
) |
|
|
697 |
|
|
|
(6,341 |
) |
(Loss) gain on derivatives |
|
(544 |
) |
|
|
4,402 |
|
|
|
(3,674 |
) |
|
|
19,158 |
|
Income tax benefit (expense) on (loss) gain on derivatives |
|
136 |
|
|
|
(1,106 |
) |
|
|
918 |
|
|
|
(4,815 |
) |
(Loss) gain on derivatives, net of taxes |
|
(408 |
) |
|
|
3,296 |
|
|
|
(2,756 |
) |
|
|
14,343 |
|
Total other comprehensive gain (loss) |
|
204 |
|
|
|
(2,940 |
) |
|
|
(2,059 |
) |
|
|
8,002 |
|
Comprehensive income (loss) |
$ |
51,032 |
|
|
$ |
(7,563 |
) |
|
$ |
(69,910 |
) |
|
$ |
(4,864 |
) |
The accompanying notes are an integral part of the consolidated financial statements.
4
WW INTERNATIONAL, INC. AND SUBSIDIARIES
UNAUDITED Consolidated Statements of Changes in Total Deficit
(IN THOUSANDS)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended July 1, 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
|
Common Stock |
|
|
Treasury Stock |
|
|
Comprehensive |
|
|
Retained |
|
|
|
|
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Loss |
|
|
Earnings |
|
|
Total |
|
Balance at April 1, 2023 |
|
|
122,052 |
|
|
$ |
0 |
|
|
|
51,418 |
|
|
$ |
(3,093,237 |
) |
|
$ |
(7,733 |
) |
|
$ |
2,298,701 |
|
|
$ |
(802,269 |
) |
Comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
204 |
|
|
|
50,828 |
|
|
|
51,032 |
|
Issuance of treasury stock under stock plans |
|
|
|
|
|
|
|
|
(272 |
) |
|
|
14,164 |
|
|
|
|
|
|
(15,195 |
) |
|
|
(1,031 |
) |
Compensation expense on share-based awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,063 |
|
|
|
3,063 |
|
Issuance of common stock |
|
|
7,996 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32,943 |
|
|
|
32,943 |
|
Balance at July 1, 2023 |
|
|
130,048 |
|
|
$ |
0 |
|
|
|
51,146 |
|
|
$ |
(3,079,073 |
) |
|
$ |
(7,529 |
) |
|
$ |
2,370,340 |
|
|
$ |
(716,262 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended July 1, 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
|
Common Stock |
|
|
Treasury Stock |
|
|
Comprehensive |
|
|
Retained |
|
|
|
|
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Loss |
|
|
Earnings |
|
|
Total |
|
Balance at December 31, 2022 |
|
|
122,052 |
|
|
$ |
0 |
|
|
|
51,496 |
|
|
$ |
(3,097,304 |
) |
|
$ |
(5,470 |
) |
|
$ |
2,418,959 |
|
|
$ |
(683,815 |
) |
Comprehensive loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,059 |
) |
|
|
(67,851 |
) |
|
|
(69,910 |
) |
Issuance of treasury stock under stock plans |
|
|
|
|
|
|
|
|
(350 |
) |
|
|
18,231 |
|